CRISPR Therapeutics (CRSP)
CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025
(UNDEFINED)
Tectonic Therapeutic Joins Russell 3000® Index
Assembly Biosciences Inc. (ASMB)
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
Eyenovia Inc. (EYEN)
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
Tyra Biosciences Inc. (TYRA)
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
Spectral AI (MDAI)
Spectral AI Announces Submission to FDA of itsDeepView® System
Tempest Therapeutics Inc. (TPST)
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
Corbus Pharmaceuticals Holdings Inc. (CRBP)
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
SenesTech Inc (SNES)
Allarity Therapeutics Inc. (ALLR)
Unity Biotechnology Inc (UBX)
New Form 8-K - Unity Biotechnology, Inc. Filed: 2025-06-30 AccNo: 0000950170-25-091210 Size: 220 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of …
SenesTech Inc (SNES)
Clene Inc. (CLNNW)
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
Revolution Medicines Inc (RVMDW)
Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors
Cidara Therapeutics Inc. (CDTX)
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes